Synthesis of phosphorylated Neisseria meningitidis inner core lipopolysaccharide structures

A phosphoethanolamine-substituted tetrasaccharide structure, 2-aminoethyl 2-acetamido-2-deoxy-α-d-glucopyranosyl-(1→2)-6-O-[2-(tert-butyloxycarbonylaminoethyl)-phosphono]-l-glycero-α-d-manno-heptopyranosyl-(1→3)-[β-d-glucopyranosyl-(1→4)]-l-glycero-α-d-manno-heptopyranoside, corresponding to the non-reducing part of the conserved part of Neisseria meningitidis lipopolysaccharides has been synthesized. Orthogonal protection of the phosphoethanolamino group in combination with the presence of a free amino-containing anomeric spacer allows conjugation to proteins to construct conjugate vaccine candidates. The tetrasaccharide is built up using a linear strategy, where the introduction of the terminal α-GlcNAc moiety is performed using a 2-azido-thioglucoside as a donor and NIS/AgOTf as a promoter. The synthetic pathway includes tetrasaccharide intermediates appropriately designed to permit other phosphorylation patterns as well as elongation at the reducing end.